THERAVECTYS

THERAVECTYS

THERAVECTYS

THERAVECTYS develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Founded
2005
Raised
$28.3M
Follow us
Alexa global traffic share
Latest funding
$18,913,020
Venture capital (Series D) - 2013
Tethys BioScience
$9,409,092
Venture capital (Series C) - 2012
Guy PAILLAUD John PIETERS Philippe ODDO +1
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when THERAVECTYS makes some noise.